Friday, July 10, 2026

pharma · Diphtheria · Diabetes Mellitus, Type 2

Sanofi Pasteur MSD

Sanofi Pasteur MSD clinical programs — 15 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

France, LYON HQ
363 Employees
EMA registrant Type
Company details
Status
Public
HQ
France, LYON
Employees
363
Programs
83
Drugs
66
Patents
0
Intelligence · Clinical Programs

Sanofi Pasteur MSD projects

15 ClinicalTrials.gov programs sponsored by Sanofi Pasteur MSD.

Sanofi Pasteur MSD has 15 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Bacillus Clausii Multi ATB Resist

    Sanofi Pasteur

    Diarrhea, Infantile

    approved small molecule completed

    1 trial
  2. Dupilumab

    Sanofi Pasteur

    Asthma

    approved small molecule active

    2 trials
  3. Enoxaparin

    Sanofi Pasteur

    Acute Illness

    approved small molecule completed

    1 trial
  4. Fexofenadine

    Sanofi Pasteur

    Rhinitis, Allergic, Perennial

    approved small molecule completed

    1 trial
  5. Fexofenadine HCL and pseudoephedrine HCL

    Sanofi Pasteur

    Rhinitis Allergic

    approved small molecule completed

    1 trial
  6. INSULIN GLARGINE (HOE901)

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial
  7. Insulin Glargine

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials
  8. Insulin glulisine

    Sanofi Pasteur

    Diabetes Mellitus, Type 1

    approved small molecule completed

    1 trial
  9. Lixisenatide (AVE0010)

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule completed

    3 trials
  10. RAMIPRIL HOE498

    Sanofi Pasteur

    Coronary Artery Disease

    approved small molecule completed

    1 trial
  11. Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

    Sanofi Pasteur

    Cholera

    approved mab completed

    1 trial
  12. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease (Infantile-Onset)

    approved mab terminated

    1 trial
  13. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease

    approved mab completed

    1 trial
  14. rFVIIIFc

    Sanofi Pasteur

    Hemophilia A With Inhibitors

    approved mab completed

    1 trial
  15. risedronate sodium

    Sanofi Pasteur

    Osteoporosis, Postmenopausal

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Sanofi Pasteur MSD have?

15 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.